Serveur d'exploration SRAS - Exploration (Accueil)

Index « MeshFr.i » - entrée « Cysteine endopeptidases »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Cyclotides < Cysteine endopeptidases < Cysteine proteases  Facettes :

List of bibliographic references indexed by Cysteine endopeptidases

Number of relevant bibliographic references: 176.
[20-40] [0 - 20][0 - 50][40-60]
Ident.Authors (with country if any)Title
001213 (2015) Kai-Wen Cheng [Taïwan] ; Shu-Chun Cheng [Taïwan] ; Wei-Yi Chen [Taïwan] ; Min-Han Lin [Taïwan] ; Shang-Ju Chuang [Taïwan] ; I-Hsin Cheng [Taïwan] ; Chiao-Yin Sun [Taïwan] ; Chi-Yuan Chou [Taïwan]Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus.
001237 (2015) Danielle Needle [États-Unis] ; George T. Lountos [États-Unis] ; David S. Waugh [États-Unis]Structures of the Middle East respiratory syndrome coronavirus 3C-like protease reveal insights into substrate specificity.
001247 (2015) Justin K. Taylor [États-Unis] ; Christopher M. Coleman [États-Unis] ; Sandra Postel [États-Unis] ; Jeanne M. Sisk [États-Unis] ; John G. Bernbaum [États-Unis] ; Thiagarajan Venkataraman [États-Unis] ; Eric J. Sundberg [États-Unis] ; Matthew B. Frieman [États-Unis]Severe Acute Respiratory Syndrome Coronavirus ORF7a Inhibits Bone Marrow Stromal Antigen 2 Virion Tethering through a Novel Mechanism of Glycosylation Interference.
001269 (2015) Michael Berry [Afrique du Sud] ; Burtram C. Fielding [Afrique du Sud] ; Junaid Gamieldien [Afrique du Sud]Potential Broad Spectrum Inhibitors of the Coronavirus 3CLpro: A Virtual Screening and Structure-Based Drug Design Study.
001289 (2015) Sakshi Tomar ; Melanie L. Johnston [États-Unis] ; Sarah E. St John ; Heather L. Osswald [États-Unis] ; Prasanth R. Nyalapatla [États-Unis] ; Lake N. Paul ; Arun K. Ghosh [États-Unis] ; Mark R. Denison [États-Unis] ; Andrew D. Mesecar [États-Unis]Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro): IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS.
001297 (2015) Hyun Lee [États-Unis] ; Hao Lei [États-Unis] ; Bernard D. Santarsiero [États-Unis] ; Joseph L. Gatuz [États-Unis] ; Shuyi Cao [États-Unis] ; Amy J. Rice [États-Unis] ; Kavankumar Patel [États-Unis] ; Michael Z. Szypulinski [États-Unis] ; Isabel Ojeda ; Arun K. Ghosh [États-Unis] ; Michael E. Johnson [États-Unis]Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV.
001307 (2015) Michael Berry [Afrique du Sud] ; Burtram Fielding [Afrique du Sud] ; Junaid Gamieldien [Afrique du Sud]Human coronavirus OC43 3CL protease and the potential of ML188 as a broad-spectrum lead compound: homology modelling and molecular dynamic studies.
001543 (2014) Yahira M. Báez-Santos ; Sarah E. St. John ; Andrew D. MesecarThe SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds
001545 (2014) Krystal Matthews [États-Unis] ; Alexandra Sch Fer [États-Unis] ; Alissa Pham [États-Unis] ; Matthew Frieman [États-Unis]The SARS coronavirus papain like protease can inhibit IRF3 at a post activation step that requires deubiquitination activity
001563 (2014) K B Wong [Hong Kong] ; D C C. Wan [Hong Kong] ; H F Chow [Hong Kong]Substrate specificity and rational design of peptidomimetic inhibitors for SARS coronavirus main protease.
001568 (2014) Min-Han Lin ; Shang-Ju Chuang ; Chiao-Che Chen ; Shu-Chun Cheng ; Kai-Wen Cheng ; Chao-Hsiung Lin ; Chiao-Yin Sun [Taïwan] ; Chi-Yuan ChouStructural and functional characterization of MERS coronavirus papain-like protease.
001569 (2014) Kiira Ratia [États-Unis] ; Andrew Kilianski [États-Unis] ; Yahira M. Baez-Santos [États-Unis] ; Susan C. Baker [États-Unis] ; Andrew Mesecar [États-Unis]Structural Basis for the Ubiquitin-Linkage Specificity and deISGylating activity of SARS-CoV papain-like protease.
001594 (2014) C P Chuck [Hong Kong] ; Z H Ke [Hong Kong] ; C. Chen [Hong Kong] ; D C C. Wan [Hong Kong] ; H F Chow [Hong Kong] ; K B Wong [Hong Kong]Profiling of substrate-specificity and rational design of broad-spectrum peptidomimetic inhibitors for main proteases of coronaviruses.
001604 (2014) Yeong Hun Song ; Dae Wook Kim ; Marcus John Curtis-Long ; Heung Joo Yuk ; Yan Wang ; Ningning Zhuang ; Kon Ho Lee ; Kwon Seok Jeon ; Ki Hun ParkPapain-like protease (PLpro) inhibitory effects of cinnamic amides from Tribulus terrestris fruits.
001660 (2014) Liangzhong Lim [Singapour] ; Jiahai Shi [Singapour] ; Yuguang Mu ; Jianxing Song [Singapour]Dynamically-Driven Enhancement of the Catalytic Machinery of the SARS 3C-Like Protease by the S284-T285-I286/A Mutations on the Extra Domain
001834 (2013) Zhilin Ren [République populaire de Chine] ; Liming Yan ; Ning Zhang ; Yu Guo ; Cheng Yang ; Zhiyong Lou ; Zihe RaoThe newly emerged SARS-like coronavirus HCoV-EMC also has an "Achilles' heel": current effective inhibitor targeting a 3C-like protease.
001850 (2013) Hyun Lee [États-Unis] ; Shuyi Cao ; Kirk E. Hevener ; Lena Truong ; Joseph L. Gatuz ; Kavankumar Patel ; Arun K. Ghosh ; Michael E. JohnsonSynergistic inhibitor binding to the papain-like protease of human SARS coronavirus: mechanistic and inhibitor design implications.
001876 (2013) Qi Zhao [États-Unis] ; Erin Weber ; Haitao YangRecent developments on coronavirus main protease/3C like protease inhibitors.
001903 (2013) Cheng Guo Wu [Taïwan] ; Shu Chun Cheng ; Shiang Chuan Chen ; Juo Yan Li ; Yi Hsuan Fang ; Yau Hung Chen ; Chi Yuan ChouMechanism for controlling the monomer-dimer conversion of SARS coronavirus main protease.
001933 (2013) Jung Keun Cho [Corée du Sud] ; Marcus J. Curtis-Long ; Kon Ho Lee ; Dae Wook Kim ; Hyung Won Ryu ; Heung Joo Yuk ; Ki Hun ParkGeranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia tomentosa.
001961 (2013) Pillaiyar Thanigaimalai [Japon] ; Sho Konno ; Takehito Yamamoto ; Yuji Koiwai ; Akihiro Taguchi ; Kentaro Takayama ; Fumika Yakushiji ; Kenichi Akaji ; Shen-En Chen ; Aurash Naser-Tavakolian ; Arne Schön ; Ernesto Freire ; Yoshio HayashiDevelopment of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: design, synthesis, biological evaluation, and docking studies.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i -k "Cysteine endopeptidases" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i  \
                -Sk "Cysteine endopeptidases" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    MeshFr.i
   |clé=    Cysteine endopeptidases
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021